Circulation: Heart Failure Online

An American Heart Association Journal
Circulation: Heart Failure Online 19413297
ISBN/ISSN: 19413297
Term (Number of years)
Quantity
Select a Price:

Select a Country:
  close

Journal Pricing

The following options and terms will help you in choosing your LWW subscription.
Single Issues:   You can order single issues of most journals. Pricing and ordering information are available here.
Institutional Rates:   These rates apply to libraries, hospitals, corporations, and partnerships of three (3) or more individuals.
International Rates:   International rates apply when the final destination of the subscription lies in Canada, Mexico, and all other countries outside the U.S.
Handling Charge:   A handling charge must be added to the rate of most LWW periodical publications. See the "Plus Handling" column on the journal rate sheet.
Air Freight Charge:   Most Lippincott Williams & Wilkins periodicals are shipped via air freight service to destinations outside U.S., Canada, and Mexico. Please refer to the journal rate sheet to determine the titles with an "Overseas Shipping" charge. Where applicable, this charge IS NOT OPTIONAL and must be added to all subscription rates for countries outside the United States, Canada, and Mexico. Canadian subscribers must add GST or HST as applicable.
For other purchasing options and tools available for LWW journals, please visit the Periodical Center.

 





Promotion Code
Apply

Avoid future price increases! Lock in the current rate for up to 3 years. Select your preferred number of years and click "Subscribe".

All individual subscriptions include online access to the journal, which can be accessed through http://journals.lww.com.

 

Description

Circulation: Heart Failure is the resource for critical, high-quality, clinically relevant articles focusing on observational studies, clinical trials, epidemiology, and advances in applied (translational) research related to heart failure. You can rely on the coverage of topics such as new drug and device therapies, as well as papers illuminating the pathophysiology in human and translational models.

With an Impact Factor of 6.286, Circulation: Heart Failure is ranked 11th among 117 journals in the Cardiac & Cardiovascular Systems subject category in the 2011 Journal Citation Reports® (Thomson Reuters, 2012). 

Visit the journal online at http://circheartfailure.ahajournals.org to see for yourself just how valuable Circulation: Heart Failure is. "Editor's Picks" articles are freely accessible with every issue as is all content older than 12 months. A digital subscription includes online access - via your computer or Internet-enabled smartphone - as well as access to Circulation: Heart Failure for the iPad®. The journal's app optimizes the best in digital technology to enhance a print-like reading experience. To learn more, visit http://circheartfailure.ahajournals.org/site/misc/ipad.xhtml.


AHA Premium Professional Plus Members receive complete online access to all 11 AHA journals via the AHA Learning Library on My.AmericanHeart.org, plus access to the journals' iPad editions. Premium Professional, Early Career, and Student/Trainee Members have limited access to journals and iPad apps as indicated by selected membership level. Full access options are available for each level of Professional Membership when you join. General Professional Members pay the non-member individual subscriber rate. Visit http://my.americanheart.org/memberbenefits today!

Features

--Online archive dating back to the very first issue published in 2008
--Regular Review Series:
  • Advances in Heart Failure: Reviews focus on topics of contemporary interest to the clinician and researcher. Overviews of new concepts in pathophysiology, natural history, diagnostic strategies, and treatment approaches are included in this series. The series also includes cutting edge reviews of the scientific basis of disease.
  • Development of Therapeutics for Heart Failure: Articles will focus attention on how therapeutic strategies are developed for heart failure. The series will follow therapeutic development of drugs, devices, and regenerative strategies from animal models through human studies, and critically review clinical trial methodologies as well as regulatory issues influencing heart failure therapeutics.
  • Controversies in Heart Failure: Controversial topics in the practice of heart failure will be presented. Opposite viewpoints will be presented in tandem, with rebuttal responses by both authors included.
--Special sections: book reviews, Challenges for the Basis of Practice, correspondence, Images and Case Reports in Heart Failure 
 
All non-member individual and in-training digital subscriptions include online access at http://circheartfailure.ahajournals.org as well as the iPad® edition. 

Institutional online access is available on Ovid. Visit www.ovid.com or contact your Ovid Sales Representative directly.

About the Editor(s)

Specs

  • ISSN: 19413297
  • Published: Published Bimonthly

Associated Specialties